Indian drugmaker Morepen Laboratories Ltd has filed an international patent for the manufacturing process of Desloratadine, the Bombay Stock Exchange said on Wednesday.
The company is also working on the process to obtain US Food Drug Administration approval for the $500
drug million meant for treatment of allergy, cough and cold.Its shares were down 1.7 per cent at Rs 22.30 on the Bombay Stock Exchange.
Source:
© Copyright 2024 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
